0
RAPT Therapeutics, Inc. Banner Image

RAPT Therapeutics, Inc. has reached its limit for free report views

Work for RAPT Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

RAPT Therapeutics, Inc.

  • Ticker RAPT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
RAPT Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate theMore critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. The Company is also pursuing a range of targets, including hematopoietic progenitor kinase 1 (HPK1) and general control nonderepressible 2 (GCN2), that are in the discovery stage of development.
RAPT Therapeutics, Inc.

Most Recent Annual Report

RAPT Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. RAPT Therapeutics, Inc. has reached its limit for free report views.